Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial

Overview of attention for article published in Journal for Immunotherapy of Cancer, October 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

blogs: 1 blog

twitter: 7 X users

Citations

dimensions_citation: 47 Dimensions

Readers on

mendeley: 50 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 11 X posts from 7 X users, with an upper bound of 55,887 followers.

RT @jitcancer: #JITC Research: Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma…

23 Nov 2019

Reply Repost Favourite

#JITC Research: Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial https://t.co/10Se7iZitr https://t.co/zdnXSpnJZV

22 Nov 2019

Reply Repost Favourite

16 Nov 2019

Reply Repost Favourite

09 Nov 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.